Capital36 FIZ has acquired The Kusnacht Practice AG
February 2015 — Capital36 FIZ has acquired The Kusnacht Practice AG for an undisclosed consideration.
Capital36 FIT is a Poland-based investment fund that invests primarily in the medical sector.
The Kusnacht Practice AG treats alcoholism and drug addiction, eating disorders, gambling compulsivity, sex and love, as well as internet compulsion. The clinic’s approach involves one client working one-on-one with therapists eight hours a day. An international team of doctors, therapists, nurses, counsellors and other professionals offers a full range of addiction treatment and psychiatric services for individuals and their families. The clinic, founded in 2011, operates in the high-end sector and patients are mainly HNWIs and their relatives from all over the world.
Our role in the transaction
Oaklins' team in Switzerland conducted the financial due diligence on behalf of the buyer, providing a comprehensive financial model and business planning support and assisting them in the closing process.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more